| # | Drug | Count |
|---|---|---|
| 0 | PREDNISOLONE | 20 |
| 1 | PREDNISOLONE ORAL | 20 |
| 2 | PREDNISOLONE ORAL SOLUTION | 20 |
| 3 | AZATHIOPRINE | 13 |
| 4 | APIXABAN | 12 |
| 5 | MACITENTAN | 12 |
| 6 | SILDENAFIL | 12 |
| 7 | SILDENAFIL CITRATE | 12 |
| 8 | SILDENAFIL POWDER, | 12 |
| 9 | HYDROXYCHLOROQUINE | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETRAVIRINE | 9 | 0.0020 |
| 1 | NITROUS OXIDE | 4 | 0.0018 |
| 2 | RALTEGRAVIR | 9 | 0.0017 |
| 3 | ZIDOVUDINE | 10 | 0.0010 |
| 4 | DARUNAVIR | 10 | 0.0007 |
| 5 | PENICILLIN V POTASSIUM | 1 | 0.0004 |
| 6 | DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 1 | 0.0004 |
| 7 | SILDENAFIL POWDER, | 12 | 0.0003 |
| 8 | TELMISARTAN | 6 | 0.0003 |
| 9 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 4 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 9 | 0.0004 |
| 1 | Protease Inhibitor [EPC] | 11 | 0.0002 |
| 2 | Cytochrome P450 3A Inhibitor [EPC] | 11 | 0.0002 |
| 3 | Purine Antimetabolite [EPC] | 13 | 0.0001 |
| 4 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 11 | 0.0001 |
| 6 | Phosphodiesterase 5 Inhibitor [EPC] | 12 | 0.0001 |
| 7 | Prostacycline Vasodilator [EPC] | 11 | 0.0001 |
| 8 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 9 | Prostaglandin E1 Analog [EPC] | 1 | 0.0001 |